u/dose_diary_dana

nothing in this board is legal advice

How long have you been logging?

progress is not linear and nobody’s is

Removed advice aimed at another member. Describe your own experience here.

A log is a record of what you did. It is not a protocol, and posting one as a schedule for other members is a different thing that this board does not do.

pack sizes differ, so per-month comparisons need care

non-scale victories count and they are the ones people remember

Left up. Dates, consistent conditions and annotations, which is the standard here.

Left up. It is a milestone post with a timeframe attached, which is all we ask.

deadlines run from the letter date, not from when you opened it

Agreed on the no-names rule. It protects the board and it protects people who turn out to be wrong.

Yes. Written, always, even when they tell you a phone call is sufficient.

Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.

Removed advice aimed at another member. Describe your own experience here.

Asked the supplier what documentation travels with the shipment and got a straight answer. That was reassuring in itself.

Those criteria were revised at renewal, so the version quoted upthread is out of date.

Right, and keeping every date and reference number turns a frustrating process into an auditable one.

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

Yes — log what happened rather than what you intended. My retrospective entries were quietly wrong every time.

Same. Naming the country in the first line would fix most of the bad advice on this board.

Left up. Dates, consistent conditions and annotations, which is the standard here.

identity testing matters more here than purity does

I would not read one pharmacy’s cash price as the going rate. The spread is real.

The evidence base, described honestly, which almost no summary of it does.

The published literature is overwhelmingly preclinical and largely in rodent models. The individual papers are generally more modest in their claims than the summaries that circulate. Human clinical trial evidence for the claims most often repeated in these threads is very limited.

That is not an argument that nothing is happening in the preclinical work — some of it is genuinely interesting. It is an argument that the distance between "this happened in a rodent model" and "this will happen in a person" is large, uncertain, and crossed silently in nearly every confident post on this board, including some of mine from two years ago.

I would not read one pharmacy’s cash price as the going rate. The spread is real.

Never name an individual. The sidebar rule exists because the cost of being wrong falls on a person and the benefit of being right falls on nobody in particular.

quantity limits are as common a barrier as coverage itself

This is why every thread here needs a province in it.

That is a report count, not a test count, and it changes how thin the evidence base actually is.

That is a waist measurement, not a weight, and the thread has been comparing them as though they were the same.

goal weights chosen at week one are usually guesses

Stopped reading the fastest posts here for a month and my mood improved considerably.

Removed an image link. This board is text only by community rule and that has been reaffirmed twice.

the middle is the part nobody posts and everybody lives in

Right, and the group-buy structure is the underrated risk here. One person holds everything and there is no recourse designed in.

Nobody has to post a starting weight, and comments demanding one get removed.

Left up. It is a milestone post with a timeframe attached, which is all we ask.

the tendon claims are the most repeated and the least evidenced

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

Rate of change is not a virtue. Slower trajectories are as durable as fast ones and are considerably better represented on this board than the front page suggests.